Ogunade et al., 2016 - Google Patents
Effects of 3 sequestering agents on milk aflatoxin M1 concentration and the performance and immune status of dairy cows fed diets artificially contaminated with …Ogunade et al., 2016
View HTML- Document ID
- 17816777654054743003
- Author
- Ogunade I
- Arriola K
- Jiang Y
- Driver J
- Staples C
- Adesogan A
- Publication year
- Publication venue
- Journal of dairy science
External Links
Snippet
This study examined whether adding 3 mycotoxin-sequestering agents to diets contaminated with aflatoxin B 1 (AFB 1) would reduce milk aflatoxin M 1 (AFM 1) concentration, and improve the performance and alter immune status of dairy cows. Fifteen …
- 235000005911 diet 0 title abstract description 117
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ogunade et al. | Effects of 3 sequestering agents on milk aflatoxin M1 concentration and the performance and immune status of dairy cows fed diets artificially contaminated with aflatoxin B1 | |
| Jiang et al. | Effect of adding clay with or without a Saccharomyces cerevisiae fermentation product on the health and performance of lactating dairy cows challenged with dietary aflatoxin B1 | |
| Xiao et al. | Effects of Saccharomyces cerevisiae fermentation products on dairy calves: Ruminal fermentation, gastrointestinal morphology, and microbial community | |
| Nemec et al. | Immune responses in lactating Holstein cows supplemented with Cu, Mn, and Zn as sulfates or methionine hydroxy analogue chelates | |
| Xiong et al. | Transfer of dietary aflatoxin B1 to milk aflatoxin M1 and effect of inclusion of adsorbent in the diet of dairy cows | |
| Queiroz et al. | Effect of adding a mycotoxin-sequestering agent on milk aflatoxin M1 concentration and the performance and immune response of dairy cattle fed an aflatoxin B1-contaminated diet | |
| Magalhães et al. | Effect of feeding yeast culture on performance, health, and immunocompetence of dairy calves | |
| Huff et al. | Bacterial clearance, heterophil function, and hematological parameters of transport-stressed turkey poults supplemented with dietary yeast extract | |
| Li et al. | Effects of subacute ruminal acidosis challenges on fermentation and endotoxins in the rumen and hindgut of dairy cows | |
| Sulzberger et al. | Effects of clay after a grain challenge on milk composition and on ruminal, blood, and fecal pH in Holstein cows | |
| Wang et al. | Effects of subacute ruminal acidosis challenges on fermentation and biogenic amines in the rumen of dairy cows | |
| Cortinhas et al. | Antioxidant enzymes and somatic cell count in dairy cows fed with organic source of zinc, copper and selenium | |
| Lei et al. | Effects of dietary supplementation of montmorillonite and yeast cell wall on lipopolysaccharide adsorption, nutrient digestibility and growth performance in beef cattle | |
| US20060239992A1 (en) | Methods and compositions for the inhibition of growth of infectious aspergillus fumigatus and other mycotic organisms in the gut of mammalian and avian species | |
| Wilms et al. | Hypertonic milk replacers increase gastrointestinal permeability in healthy dairy calves | |
| Amit et al. | Self-medication with tannin-rich browse in goats infected with gastro-intestinal nematodes | |
| Xiong et al. | Effects of dietary adsorbent on milk aflatoxin M1 content and the health of lactating dairy cows exposed to long-term aflatoxin B1 challenge | |
| Rodrigues et al. | Feed additives containing sequestrant clay minerals and inactivated yeast reduce aflatoxin excretion in milk of dairy cows | |
| Zhou et al. | Effect of dietary β-glucan on growth performance, fecal microbial shedding and immunological responses after lipopolysaccharide challenge in weaned pigs | |
| Weatherly et al. | Physiological responses to a yeast and clay-based adsorbent during an aflatoxin challenge in Holstein cows | |
| Shen et al. | Transfer efficiency of melamine from feed to milk in lactating dairy cows fed with different doses of melamine | |
| Carvalho et al. | Feeding behaviors of transition dairy cows fed glycerol as a replacement for corn | |
| Aazami et al. | Effect of yeast cell wall and (1→ 3)-β-D-glucan on transfer of aflatoxin from feed to milk in Saanen dairy goats | |
| Hasunuma et al. | Consecutive reticular pH monitoring in dairy cows fed diets supplemented with active dry yeast during the transition and mid-lactation periods | |
| Barreto et al. | Systematic review and meta-analysis of probiotic use on inflammatory biomarkers and disease prevention in cattle |